Health & bio
Novo's Wegovy pill hits 600K prescriptions in March
Novo gets a three-month market head start ahead of Foundayo, cementing early share advantage.
Primary sources · 1
Novo gets a three-month market head start ahead of Foundayo, cementing early share advantage.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.